A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function
ConditionSkin Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-65
SponsorEpax Norway AS
About this trial
The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.
Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.
Eligibility criteria
Qualifiers
Volunteers who are able to provide signed informed consent
Healthy male or female volunteers between the ages of 35 and 65 years
Volunteers with a self-perceived history of atopic skin, prone to redness and/or dryness
Disqualifiers
Females who are pregnant, breast feeding, or have given birth within the previous 6 weeks or are planning to be pregnant during the study
Volunteers with previous experience of intolerance or allergic reactions to fish or fish products
Volunteers with an active skin disorder or a significant history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of a trained assessor or dermatologist may affect the test results
Volunteers currently taking or who have recently taken antihistamines, antibiotics, systemic anti-inflammatory drugs during the previous week
Trial design
Treatments tested in this trial
- Omega 3-9-11
- Placebo
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Epax Norway AS
Lead sponsor
Cutest Systems Ltd
Collaborator
Source ClinicalTrials.gov